Dr. Phuong Vo
Claim this profileFred Hutch/University of Washington Cancer Consortium
Studies Myelodysplastic syndrome
Studies T-Lymphoblastic Leukemia/Lymphoma
4 reported clinical trials
11 drugs studied
Area of expertise
1Myelodysplastic Syndrome
HLA-A negative
RB1 positive
HLA-A positive
2T-Lymphoblastic Leukemia/Lymphoma
HLA-A negative
RB1 positive
HLA-A positive
Affiliated Hospitals
Clinical Trials Phuong Vo is currently running
Radioimmunotherapy
for Benign Conditions
This phase I/II trial studies the best dose of total body irradiation with astatine-211 BC8-B10 monoclonal antibody for the treatment of patients with nonmalignant diseases undergoing hematopoietic cell transplant. Radiation therapy uses high energy gamma rays to kill cancer cells and shrink tumors. Astatine-211-labeled BC8-B10 monoclonal antibody is a monoclonal antibody, called anti-CD45 monoclonal antibody BC8-B10, linked to a radioactive/toxic agent called astatine 211. Anti-CD45 monoclonal antibody BC8-B10 is attached to CD45 antigen positive cancer cells in a targeted way and delivers astatine 211 to kill them. Giving astatine-211 BC8-B10 monoclonal antibody and total-body irradiation before a donor stem cell transplant may help stop the growth of cells in the bone marrow, including normal blood-forming cells (stem cells) and cancer cells. It may also stop the patient's immune system from rejecting the donor's stem cells.
Recruiting1 award Phase 1 & 211 criteria
Treosulfan-Based vs Clofarabine-Based Conditioning
for Leukemia
This phase II trials studies the effect of treosulfan-based versus clofarabine-based conditioning regimens before donor hematopoietic stem cell transplant in treating patients with myelodysplastic syndromes or acute myeloid leukemia. Chemotherapy drugs, such as treosulfan, fludarabine, and clofarabine, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving chemotherapy and total-body irradiation before a donor hematopoietic stem cell transplant helps kill cancer cells in the body and helps make room in the patient's bone marrow for new blood-forming cells (stem cells) to grow. When the healthy stem cells from a donor are infused into a patient, they may help the patient's bone marrow make more healthy cells and platelets and may help destroy any remaining cancer cells. This study may help doctors determine whether treosulfan-based or clofarabine-based conditioning regimen works better before donor hematopoietic stem cell transplant in treating patients with myelodysplastic syndromes or acute myeloid leukemia.
Recruiting1 award Phase 2
More about Phuong Vo
Clinical Trial Related5 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Phuong Vo has experience with
- Total-Body Irradiation
- Cyclophosphamide
- Astatine At 211 Anti-CD45 Monoclonal Antibody BC8-B10
- Clofarabine
- Hematopoietic Cell Transplantation
- Treosulfan
Breakdown of trials Phuong Vo has run
Myelodysplastic syndrome
T-Lymphoblastic Leukemia/Lymphoma
Myelodysplastic Syndrome
Postprandial Fullness Syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Phuong Vo specialize in?
Phuong Vo focuses on Myelodysplastic syndrome and T-Lymphoblastic Leukemia/Lymphoma. In particular, much of their work with Myelodysplastic syndrome has involved HLA-A negative patients, or patients who are RB1 positive.
Is Phuong Vo currently recruiting for clinical trials?
Yes, Phuong Vo is currently recruiting for 3 clinical trials in Seattle Washington. If you're interested in participating, you should apply.
Are there any treatments that Phuong Vo has studied deeply?
Yes, Phuong Vo has studied treatments such as Total-Body Irradiation, Cyclophosphamide, Astatine At 211 Anti-CD45 Monoclonal Antibody BC8-B10.
What is the best way to schedule an appointment with Phuong Vo?
Apply for one of the trials that Phuong Vo is conducting.
What is the office address of Phuong Vo?
The office of Phuong Vo is located at: Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington 98109 United States. This is the address for their practice at the Fred Hutch/University of Washington Cancer Consortium.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.